Capricor, Nippon Extend Partnership
PHARMA: $735M Europe Distribution Agreement
■ By JENNIFER KASTNER
TABLE OF CONTENTS
LA JOLLA – Torrey Pines biotech innovator Capricor Therapeutics (Nasdaq: CAPR) signed a massive new deal with Japanese biopharma leader Nippon Shinyaku (TYO: 4516) for the European commercialization and distribution of Capricor’s leading drug –...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.